Search

everythinglearnresearchcommunity

for

Search:↓

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Combining paroxetine and triamcinolone effectively treats both alopecia areata and depression.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

CAM offers natural hair care solutions that may improve hair health and growth with fewer side effects.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Baricitinib helps treat severe hair loss in people over 65.

Baricitinib is effective as a treatment for severe hair loss.

A 7-year-old boy's hair regrew and his well-being improved after homeopathic treatment for alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Baricitinib successfully treated severe hair loss.